MRI-derived extracellular volume fraction as a prognostic biomarker for early recurrence after R0 resection of pancreatic ductal adenocarcinoma
MRI-derived tumor ECV is a robust, reproducible biomarker for predicting early recurrence after R0 resection in PDAC patients, potentially assisting in preoperative risk stratification.
Authors
- Liang Zhu (ORCID: https://orcid.org/0000-0003-3779-7853)
- Menghua Dai (ORCID: https://orcid.org/0000-0002-7273-6282)
- Yi‐Tong Lu
- Jing-Yi Liu (ORCID: https://orcid.org/0000-0002-7435-8983)
- Robert Grimm (ORCID: https://orcid.org/0000-0002-1233-8215)
- Qi Wang (ORCID: https://orcid.org/0000-0002-5324-8988)
- Yueluan Jiang (ORCID: https://orcid.org/0009-0004-5680-8102)
- Dominik Nichel
Institutions
- Siemens (Germany) (DE)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Siemens Healthineers (Germany) (DE)
- Siemens (China) (CN)
Publication Details
- Journal
- European Journal of Radiology Open
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1016/j.ejro.2025.100711
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00